Eligibility criteria
Condition
Metastatic Renal Cell Carcinoma
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- Diagnosed with mRCC
- Initiated treatment post mRCC diagnosis and received sunitinib as first-line therapy
- Age 18 years or over at the time of mRCC diagnosis
- Actively treated at an IMDC clinical center
Exclusion criteria
Show details
- Initiated first line sunitinib treatment before 2010
- Had non-clear cell mRCC